<code id='1966DB7685'></code><style id='1966DB7685'></style>
    • <acronym id='1966DB7685'></acronym>
      <center id='1966DB7685'><center id='1966DB7685'><tfoot id='1966DB7685'></tfoot></center><abbr id='1966DB7685'><dir id='1966DB7685'><tfoot id='1966DB7685'></tfoot><noframes id='1966DB7685'>

    • <optgroup id='1966DB7685'><strike id='1966DB7685'><sup id='1966DB7685'></sup></strike><code id='1966DB7685'></code></optgroup>
        1. <b id='1966DB7685'><label id='1966DB7685'><select id='1966DB7685'><dt id='1966DB7685'><span id='1966DB7685'></span></dt></select></label></b><u id='1966DB7685'></u>
          <i id='1966DB7685'><strike id='1966DB7685'><tt id='1966DB7685'><pre id='1966DB7685'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:669
          Photo illustration of newspaper clips written by Lawrence K Altman about presidents' health – opinion coverage from STAT
          Alex Hogan/STAT

          When I interviewed Ronald Reagan about his health in 1980, he was 69 and poised to become the oldest person to be elected president. During our conversation, Reagan was mentally sharp. In a light moment he feigned a wrenched back and asked what I (a physician) would do for it.

          I asked him about his mother’s health, and he told me that his mother had symptoms suggestive of dementia before she died. I asked what he would do if, as president, he developed the same ailment, and how he would know he had it. His doctors would follow him, he said, and he would resign if they found evidence of cognitive decline. Years later, those remarks would seem particularly noteworthy.

          advertisement

          The interview was likely the first in which a future president and his doctors discussed the leader’s health prospectively. (That cooperation was short-lived; Reagan’s aides did not allow reporters to interview him or his doctors when he ran for re-election after what some regarded as a poor debate performance with Walter Mondale.)

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Merck drug for rare lung condition set for approval in U.S.
          Merck drug for rare lung condition set for approval in U.S.

          AdobeTheFoodandDrugAdministrationisexpectedtoapproveMerck’sdrugtotreatararelungdisordercalledpulmona

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          The Readout: Lenmeldy, GLP

          AdobeTodayistheinauguralpublishingdayforAdam’sBiotechScorecard—asubscriber-onlynewsletterofferingsen